Concepedia

Birginia Espinoza

BE

Statistics

Publications

3

Citations

102

H-Index

3

Active since

2022

Affiliations

Sidney Kimmel Comprehensive Cancer Center(Current)

Johns Hopkins University

Johns Hopkins Medicine

Bloomberg (United States)

Bristol-Myers Squibb (United States)

Birginia Espinoza is an author at Sidney Kimmel Comprehensive Cancer Center specializing in immune checkpoint inhibitors, immunology, and combination immunotherapy.

ORCID

Publications per year

2022–2024

3

Publications

3

CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma

Jianxin Wang, May Tun Saung, Keyu Li et al. · The Journal of Experimental Medicine · 2022 · 64 citations · Full text

, , +17

CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic Cancer

Yao Xu, Juan Fu, MacKenzie Henderson et al. · Gastroenterology · 2023 · 24 citations · Full text

, , +17

Targeting heterogeneous tumor microenvironments in pancreatic cancer mouse models of metastasis by TGF-β depletion

Sophia Y. Chen, Heng‐Chung Kung, Birginia Espinoza et al. · JCI Insight · 2024 · 14 citations · Full text

, , +17

1–3 of 3